Geron (GERN) Analysts See $-0.04 EPS; Profile of 3 Analysts Covering SUPERVALU Inc. (SVU)

February 21, 2018 - By Darrin Black

Analysts expect Geron Corporation (NASDAQ:GERN) to report $-0.04 EPS on March, 7.They anticipate $0.01 EPS change or 20.00% from last quarter’s $-0.05 EPS. After having $-0.04 EPS previously, Geron Corporation’s analysts see 0.00% EPS growth. The stock decreased 5.88% or $0.14 during the last trading session, reaching $2.24. About 2.37 million shares traded or 6.22% up from the average. Geron Corporation (NASDAQ:GERN) has risen 13.81% since February 21, 2017 and is uptrending. It has underperformed by 2.89% the S&P500.

Among 9 analysts covering Supervalu Inc. (NYSE:SVU), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. Supervalu Inc. had 30 analyst reports since July 24, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Sector Perform” rating and $10.0 target in Tuesday, October 20 report. The stock of SUPERVALU Inc. (NYSE:SVU) earned “Equal-Weight” rating by Morgan Stanley on Thursday, October 19. The firm has “Buy” rating given on Thursday, January 11 by RBC Capital Markets. The stock has “Hold” rating by Credit Suisse on Wednesday, April 12. The rating was maintained by RBC Capital Markets on Friday, April 28 with “Buy”. Goldman Sachs reinitiated the stock with “Sell” rating in Tuesday, November 14 report. The stock of SUPERVALU Inc. (NYSE:SVU) has “Equal Weight” rating given on Wednesday, July 29 by Morgan Stanley. Telsey Advisory Group maintained the shares of SVU in report on Friday, September 9 with “Market Perform” rating. On Thursday, October 19 the stock rating was downgraded by Northcoast to “Neutral”. The rating was upgraded by RBC Capital Markets to “Outperform” on Thursday, March 23. See SUPERVALU Inc. (NYSE:SVU) latest ratings:

11/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $34.0 Maintain
14/11/2017 Broker: Goldman Sachs Rating: Sell New Target: $14 Reinitiate
03/11/2017 Broker: Wells Fargo Rating: Market Perform New Target: $16 Initiates Coverage On
19/10/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $22.5 New Target: $20.5 Maintain
19/10/2017 Broker: Northcoast Old Rating: Buy New Rating: Neutral Downgrade
13/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $42.0 Maintain
28/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $42.0 Maintain
23/08/2017 Broker: Pivotal Research Rating: Buy New Target: $42.0 Maintain

Among 3 analysts covering Geron (NASDAQ:GERN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Geron had 5 analyst reports since August 8, 2015 according to SRatingsIntel. The stock has “Outperform” rating by FBR Capital on Tuesday, September 13. Stifel Nicolaus maintained Geron Corporation (NASDAQ:GERN) rating on Tuesday, August 1. Stifel Nicolaus has “Hold” rating and $2.5000 target. As per Monday, December 7, the company rating was maintained by Piper Jaffray. On Saturday, August 8 the stock rating was downgraded by Zacks to “Hold”. The stock of Geron Corporation (NASDAQ:GERN) earned “Buy” rating by MLV on Monday, August 10.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.24, from 1.21 in 2017Q2. It dropped, as 10 investors sold Geron Corporation shares while 27 reduced holdings. 11 funds opened positions while 25 raised stakes. 61.75 million shares or 0.63% more from 61.36 million shares in 2017Q2 were reported. Nationwide Fund Advsrs has 87,642 shares. California State Teachers Retirement Sys holds 0% or 240,167 shares in its portfolio. 138,882 are owned by State Board Of Administration Of Florida Retirement System. Northwestern Mutual Wealth Mgmt holds 0% or 2,000 shares. Principal accumulated 23,069 shares. Prudential Fincl Inc accumulated 0% or 13,887 shares. Raymond James Fin reported 82,426 shares. Creative Planning reported 181,713 shares stake. Wells Fargo Mn reported 0% stake. Great West Life Assurance Com Can stated it has 13,098 shares. Morgan Stanley holds 0% or 254,169 shares. Voya Investment Management Limited Liability Company has 0% invested in Geron Corporation (NASDAQ:GERN) for 79,449 shares. Barclays Public Llc invested 0% of its portfolio in Geron Corporation (NASDAQ:GERN). Federated Pa accumulated 1,278 shares or 0% of the stock. Alliancebernstein L P stated it has 0% in Geron Corporation (NASDAQ:GERN).

Geron Corporation operates as a biopharmaceutical company. The company has market cap of $356.68 million. The firm supports the clinical stage development of a telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It currently has negative earnings. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses.

Investors sentiment decreased to 0 in Q3 2017. Its down 1.01, from 1.01 in 2017Q2. It is negative, as 167 investors sold SUPERVALU Inc. shares while 3 reduced holdings. 0 funds opened positions while 0 raised stakes. 83,422 shares or 99.96% less from 195.02 million shares in 2017Q2 were reported. Greenwich Wealth Management Ltd invested 0.07% in SUPERVALU Inc. (NYSE:SVU). Seabridge Invest Advsr Ltd accumulated 1,621 shares. Gotham Asset Management Limited holds 0.02% or 63,049 shares.

The stock decreased 5.46% or $0.82 during the last trading session, reaching $14.19. About 1.57 million shares traded or 5.95% up from the average. SUPERVALU Inc. (NYSE:SVU) has declined 12.69% since February 21, 2017 and is downtrending. It has underperformed by 29.39% the S&P500.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company has market cap of $545.02 million. The firm operates through two divisions, Wholesale and Retail. It has a 0.88 P/E ratio. The Wholesale segment engages in the wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store operators, regional chains, and the military.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.